Regulus Therapeutics Inc (RGLS)

Finanzdaten der Regulus Therapeutics Inc-Aktie (RGLS)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	6.34% 8.826	8.30	8.125	7.315	7.369
Interest Income/Expense	28.95% 0.081	0.114	0.137	0.168	0.185
Operating Income/Loss	6.34% -8.826	-8.30	-8.125	-7.315	-7.369
Income/Loss From Continuing Operations Before Tax	5.06% -8.469	-8.061	-7.824	-7.012	-7.139
Income/Loss From Continuing Operations After Tax	5.06% -8.469	-8.061	-7.824	-7.013	-7.139
Net Income/Loss	5.06% -8.469	-8.061	-7.824	-7.013	-7.139
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	6,661% 28.75	0.4252	19.63	19.10	16.84
Diluted Average Shares	6,661% 28.75	0.4252	19.63	19.10	16.84
Basic Earnings Per Share	110.47% -0.29	2.77	-0.40	-0.37	-0.42
Diluted Earnings Per Share	110.47% -0.29	2.77	-0.40	-0.37	-0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-